Changes in miR-124-1, miR-212, miR-132, miR-134, and miR-155 Expression Patterns after 7,12-Dimethylbenz(a)anthracene Treatment in CBA/Ca Mice

Cells. 2022 Mar 17;11(6):1020. doi: 10.3390/cells11061020.

Abstract

Specific gene and miRNA expression patterns are potential early biomarkers of harmful environmental carcinogen exposures. The aim of our research was to develop an assay panel by using several miRNAs for the rapid screening of potential carcinogens. The expression changes of miR-124-1, miR-212, miR-132, miR-134, and miR-155 were examined in the spleen, liver, and kidneys of CBA/Ca mice, following the 20 mg/bwkg intraperitoneal 7,12-dimethylbenz(a)anthracene (DMBA) treatment. After 24 h RNA was isolated, the miRNA expressions were analyzed by a real-time polymerase chain reaction and compared to a non-treated control. DMBA induced significant changes in the expression of miR-134, miR-132, and miR-124-1 in all examined organs in female mice. Thus, miR-134, miR-132, and miR-124-1 were found to be suitable biomarkers for the rapid screening of potential chemical carcinogens and presumably to monitor the protective effects of chemopreventive agents.

Keywords: 7,12-dimethylbenz(a)anthracene; carcinogen; miR-124-1; miR-132; miR-134; miR-155; miR-212; miRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene* / toxicity
  • Animals
  • Anthracenes
  • Carcinogens / toxicity
  • Female
  • Mice
  • Mice, Inbred CBA
  • MicroRNAs* / genetics

Substances

  • Anthracenes
  • Carcinogens
  • MIRN132 microRNA, mouse
  • MicroRNAs
  • Mirn124 microRNA, mouse
  • Mirn155 microRNA, mouse
  • 9,10-Dimethyl-1,2-benzanthracene
  • anthracene